design
optim
nanoparticl
offer
promis
strategi
enabl
dna
vaccin
cross
variou
physiolog
barrier
elicit
specif
protect
mucos
immun
via
intranas
administr
report
new
design
nanoparticl
system
incorpor
anion
liposom
al
chitosandna
csdna
complex
enhanc
cellular
uptak
construct
alcsdna
nanoparticl
deliv
anticari
dna
vaccin
pgjapvax
nasal
mucosa
tem
result
show
alcsdna
spheric
structur
high
dna
load
abil
effect
dna
protect
nucleas
prove
gel
electrophoresi
surfac
charg
alcsdna
depend
strongli
ph
environ
enabl
intracellular
releas
load
dna
via
phmediat
manner
comparison
tradit
csdna
system
new
design
render
higher
transfect
effici
longer
resid
time
alcsdna
nasal
mucos
surfac
outstand
featur
enabl
alcsdna
induc
significantli
higher
level
secretori
iga
siga
csdna
anim
studi
longerterm
mucos
immun
hand
alcsdna
exhibit
minim
cytotox
result
suggest
develop
nanoparticl
offer
potenti
platform
dna
vaccin
packag
deliveri
effici
elicit
mucos
immun
develop
effici
safe
vaccin
remain
major
goal
globe
public
health
recent
consider
attent
focus
develop
dna
vaccin
effect
immunogen
strategi
induc
humor
cellular
immun
respons
dna
vaccin
consid
inexpens
stabl
rel
safe
compar
attenu
viral
vaccin
flexibl
integr
gene
encod
antigen
immunostimulatori
sequenc
thu
dna
vaccin
favor
worldwid
transport
vaccin
though
intramuscular
im
vaccin
still
wide
use
unfortun
usual
fail
induc
local
immun
mucos
site
tremend
infecti
agent
enter
bodi
interestingli
nasal
mucosa
attract
site
dna
vaccin
evok
system
mucos
immun
respons
due
access
lower
enzym
distribut
compar
oral
rout
dens
popul
immun
cell
often
refer
nasal
associ
lymphoid
tissu
nalt
believ
develop
vaccin
streptococuu
mutan
mutan
might
effect
strategi
prevent
control
occurr
dental
cari
previou
studi
dna
vaccin
pgjapvax
dental
cari
success
construct
encod
glu
domain
gtf
enzym
along
p
region
surfac
protein
antigen
pac
mutan
pgjapvax
induc
specif
saliva
siga
respons
serum
igg
respons
via
im
immun
anim
includ
adult
mice
rat
rabbit
monkey
addit
increas
specif
saliva
siga
found
correl
reduct
dental
cari
howev
without
adjuv
deliveri
system
singl
dna
vaccin
pgjapvax
includ
display
low
efficaci
via
administr
possibl
attribut
poor
antigen
deliveri
result
variou
physiolog
hurdl
includ
mucociliari
clearanc
enzym
degrad
poor
intern
antigen
present
cell
apc
nanoparticl
np
may
provid
ideal
solut
allevi
problem
associ
nasal
deliveri
dna
vaccin
chitosan
cs
np
special
interest
nasal
dna
vaccin
deliveri
uniqu
properti
includ
bioadhes
effect
transport
antigen
transient
open
tight
junction
cell
biocompat
low
toxic
evid
shown
dna
vaccin
complex
cs
significantli
improv
mucos
siga
level
via
administr
dna
vaccin
deliveri
system
cs
np
expect
increas
uptak
express
effici
dna
vaccin
target
cell
howev
compar
nonvir
carrier
cs
np
mediat
transfect
effici
still
rel
low
suggest
strength
electrostat
interact
cs
dna
prevent
dissoci
within
cell
thu
preclud
transcript
dna
result
low
transfect
improv
transfect
effici
csdna
complex
addit
incorpor
neg
charg
compon
reach
balanc
dna
protect
dna
releas
effect
strategi
report
coreshel
nanoparticl
system
compris
anion
plga
core
glycol
csdna
shell
surfac
shown
enabl
intracellular
releas
load
dna
via
phmediat
manner
facilit
dna
vaccin
transfect
target
cell
anion
lipid
natur
compon
eukaryot
cell
membran
shown
significantli
increas
gene
transfect
effici
cell
line
even
better
commerci
cation
liposom
addit
power
membran
fusion
abil
anion
liposom
exhibit
advantag
compar
cation
liposom
especi
cytotox
report
cation
liposom
extrem
toxic
phagocyt
cell
thu
use
caution
vivo
interestingli
mucos
immun
liposom
seem
limit
especi
depend
coadministr
costimul
caus
modul
interact
liposom
mucosa
instabl
liposom
physiolog
condit
result
inspir
us
whether
new
system
compris
al
csdna
could
render
transfect
effici
improv
mucos
immun
dna
vaccin
knowledg
littl
focus
combin
use
bioadhes
cs
al
nasal
dna
vaccin
deliveri
present
studi
use
plasmid
pgjapvax
test
dna
vaccin
prepar
csdna
alcsdna
np
character
size
zeta
potenti
two
np
differ
ph
condit
well
morpholog
use
transmiss
electron
microscopi
tem
novel
alc
dna
deliveri
system
exhibit
phmediat
dna
releas
enhanc
mucoadhes
properti
alcsdna
abl
induc
strong
mucos
immun
respons
follow
immun
balbc
mice
find
impli
synthet
np
present
appropri
nanoparticl
deliveri
system
improv
mucos
immunogen
dna
vaccin
increas
antigen
deliveri
transport
stabil
along
mucos
tract
chitosan
mw
kd
degre
deacetyl
mucin
type
iii
purchas
sigma
st
loui
usa
dioleoylphosphatidylethanolamin
dope
dopg
purchas
lipoid
ludwigshafen
germani
plasmid
pgjapvax
recombin
protein
pac
provid
prof
mingwen
fan
school
stomatolog
wuhan
univers
china
plasmid
donat
dr
sanjiv
sam
gambhir
dept
radiolog
stanford
univers
usa
dnase
kit
purchas
promega
madison
mi
usa
mous
standard
serum
bethyl
usa
goat
antimous
igg
iga
southernbiotech
usa
horseradish
peroxidas
conjug
goat
antimous
igg
iga
southernbiotech
usa
use
mono
nh
ester
purchas
ge
healthcar
buckinghamshir
uk
use
chemic
use
reagent
analyt
grade
anion
liposom
consist
dopgdop
prepar
briefli
lipid
mixtur
molar
ratio
dopg
dope
reconstitut
mm
hepe
buffer
ph
shelldri
lipid
film
follow
vortex
min
sonic
min
cs
mgml
dissolv
acet
acid
overnight
vortex
mixer
ika
germani
prior
mix
dna
cs
solut
subject
steril
filtrat
mm
syring
filter
csdna
np
prepar
ad
equal
volum
dilut
cs
solut
dna
mgml
solut
differ
np
ratio
amin
phosphat
mole
ratio
room
temperatur
use
vortex
mixer
prepar
alc
dna
np
anion
liposom
dopgdop
mgml
mm
hepe
buffer
mix
dna
mgml
solut
differ
lipiddna
ratio
ww
final
volum
ml
cs
solut
differ
np
ratio
ad
dropwis
mild
stir
ph
valu
csbase
np
adjust
character
size
distribut
zeta
potenti
np
measur
dynam
light
scatter
nano
zs
malvern
uk
np
dilut
pb
buffer
ph
stabil
room
temperatur
min
prior
measur
morpholog
np
examin
tem
convent
neg
stain
method
use
phosphotungst
acid
releas
pgjapvax
al
csdna
pb
studi
differ
ph
shaker
rpm
releas
free
dna
separ
np
centrifug
rpm
min
differ
time
interv
within
h
concentr
quantifi
use
fluoresc
dye
hoechst
measur
carri
triplic
np
incub
dnase
reaction
buffer
min
follow
addit
dnase
stop
solut
termin
reaction
dnase
inactiv
min
sampl
analyz
agaros
gel
contain
mgml
ethidium
bromid
tae
buffer
dna
detect
uv
light
use
gel
document
system
biorad
usa
equal
volum
csbase
np
aqueou
solut
mucin
mgml
mix
vortex
min
suspens
centrifug
rpm
min
supernat
mix
period
acid
incub
h
colorimetr
assay
glycoprotein
base
period
acidschiff
stain
use
determin
mucin
concentr
supernat
mucin
adsorb
csbase
np
calcul
total
free
mucin
nake
dna
use
control
human
embryon
kidney
cell
hek
atcc
usa
cultur
dmem
supplement
fetal
bovin
serum
fb
humidifi
co
incub
thermo
usa
cell
subcultur
accord
atcc
recommend
without
antibiot
cell
seed
plate
densiti
cell
per
well
transfect
proceed
approxim
confluenc
achiev
transfect
medium
dmem
without
fb
equilibr
co
ph
adjust
perform
steril
acet
acid
csluc
alcsluc
np
contain
plasmid
prepar
describ
min
transfect
cell
medium
remov
replenish
ml
transfect
medium
ph
contain
csluc
alcsluc
concentr
mg
dnawel
h
transfect
medium
remov
replac
ml
dmem
fb
cell
incub
h
harvest
use
trypsin
solut
transfect
effici
quantifi
luciferas
assay
kit
promega
usa
pei
kd
sigma
usa
use
posit
control
peiluc
complex
prepar
directli
mix
np
ratio
rel
light
unit
rlu
normal
protein
content
sampl
experi
repeat
least
three
time
fitccsdna
alfitccsdna
np
prepar
administr
rat
nasal
caviti
ml
nostril
within
min
interv
administr
h
rat
sacrif
cervic
disloc
paraformaldehyd
solut
inject
nasal
caviti
trachea
syring
fix
min
rat
mucosa
care
excis
observ
confoc
laser
scan
microscop
andor
revolut
xd
cell
atcc
usa
cultur
dmem
supplement
fb
gl
glucos
mm
lglutamin
vv
nonessenti
amino
acid
uml
penicillinstreptomycin
teer
detect
experi
cell
seed
transwel
per
insert
maintain
day
supplement
dmem
medium
chang
everi
day
integr
monolay
assay
measur
teer
use
electrod
connect
evom
wpi
usa
monolay
wash
hank
balanc
salt
solut
hbss
ph
equilibr
hbss
min
treat
dna
csdna
alcsdna
hbss
h
insert
transfer
plate
contain
ml
hbss
teer
assess
experi
repeat
least
three
time
fitcc
synthes
reaction
isothiocyan
group
fitc
amino
group
cs
detect
uptak
fitccsdna
alfitccsdna
cell
plate
cellswel
plate
allow
adher
overnight
treat
fitccsdna
alfitccsdna
concentr
mg
dnawel
cell
harvest
suspend
pb
analyz
directli
flow
cytometri
sampl
run
cytom
tm
fc
flow
cytomet
beckman
coulter
usa
analysi
done
use
cxp
softwar
abil
pgjapvax
complex
without
csbase
np
induc
immun
respons
evalu
femal
balbc
mice
age
week
anim
hous
group
five
n
free
access
food
water
specif
pathogenfre
environ
hubei
medic
laboratori
anim
center
wuhan
china
studi
carri
accord
guidelin
provid
hubei
medic
laboratori
anim
center
review
board
protocol
approv
committe
ethic
anim
experi
huazhong
univers
scienc
technolog
permit
number
scxk
surgeri
perform
sodium
pentobarbit
anesthesia
effort
made
minim
suffer
evalu
immun
respons
five
group
differ
administr
rout
perform
follow
nake
dna
nake
dna
im
csdna
al
csdna
pb
group
everi
anim
inocul
mg
plasmid
pgjapvax
small
drop
nasal
dose
carri
ml
steril
micropipett
tip
given
nostril
ml
formulationnostril
nonanesthet
anim
supin
posit
new
drop
given
former
one
inhal
anim
also
immun
mg
plasmid
pgjapvax
hepe
ph
via
im
pathway
quadricep
muscl
secondari
immun
perform
week
dose
formul
oper
procedur
saliva
serum
collect
week
last
immun
respect
anim
intraperiton
inject
ml
steril
pilocarpin
solut
mgml
order
collect
saliva
sampl
fluid
store
mm
phenylmethyl
sulfonyl
fluorid
pmsf
proteas
inhibitor
blood
collect
retroorbit
punctur
syring
serum
obtain
store
centrifug
level
specif
antibodi
pac
sampl
determin
enzymelink
immunosorb
assay
elisa
well
plate
costar
usa
coat
purifi
mgml
protein
pac
ph
carbon
buffer
coat
overnight
plate
block
bovin
serum
albumin
bsa
pb
contain
tween
pbst
h
wash
five
time
pbst
dilut
saliva
dilut
serum
dilut
ad
well
incub
min
standard
curv
establish
coat
plate
unconjug
goat
antimous
igg
iga
mgml
serial
dilut
refer
serum
use
creat
standard
curv
ad
duplic
well
incub
h
subsequ
plate
wash
five
time
pbst
react
peroxidaseconjug
goat
antimous
igg
dilut
peroxidaseconjug
goat
antimous
iga
dilut
pbst
wash
plate
follow
ad
tmb
substrat
h
incub
min
reaction
stop
h
optic
densiti
od
read
taken
record
nm
sampl
specif
antibodi
concentr
calcul
base
multiparamet
logist
algorithm
final
result
count
accord
standard
curv
nirf
dye
modifi
amino
group
cs
realtim
imag
vivo
nasal
resid
time
measur
perform
accord
protocol
describ
hagenaar
et
al
briefli
femal
balbc
nunu
mice
age
week
hubei
medic
laboratori
anim
center
wuhan
china
anesthet
isofluran
prior
administr
ml
np
wipe
nose
paper
towel
mice
immedi
scan
ivi
spectrum
imag
system
calip
life
filter
measur
mice
put
back
cage
recov
anesthesia
order
calcul
mean
fluoresc
nasal
caviti
specif
signal
separ
background
fluoresc
spectral
unmix
live
imag
softwar
calip
life
scienc
region
interest
roi
nasal
caviti
detect
quantifi
softwar
fluoresc
emiss
imag
normal
report
photon
per
second
per
centimet
squar
per
steradian
pscm
sr
fluoresc
intens
set
statist
analysi
specif
antibodi
level
perform
spss
softwar
differ
differ
group
determin
oneway
analysi
varianc
anova
follow
post
hoc
analysi
lsd
test
comparison
deem
signific
highli
signific
gel
electrophoresi
wide
use
monitor
affin
capabl
dna
adsorb
test
np
shown
fig
pgjapvax
complet
compact
cs
np
ratio
reach
contrast
partial
dissoci
pgjapvax
csdna
observ
np
ratio
although
obviou
migrat
dna
detect
csdna
np
ratio
less
dna
retard
compar
higher
np
ratio
np
therefor
csdna
prepar
np
ratio
subsequ
experi
shown
fig
signific
dna
releas
observ
incorpor
al
csdna
variou
lipiddna
ratio
ww
fix
np
ratio
influenc
al
incorpor
size
pdi
zeta
potenti
encapsul
effici
summar
tabl
increas
amount
al
incorpor
size
alcsdna
increas
pdi
decreas
notabl
addit
modif
cs
fitc
interfer
dna
encapsul
fig
alcsdna
effect
protect
dna
degrad
dnase
wherea
nake
dna
easili
digest
low
concentr
dnase
uml
peidna
also
shown
high
dna
load
high
resist
dnase
result
indic
alcsdna
could
success
prepar
high
dna
load
high
dnase
resist
high
enough
electrostat
interact
cs
dna
might
respons
effect
dna
load
presum
caus
inabl
enzym
reach
substrat
dna
physiolog
condit
mucos
membran
surfac
larg
quantiti
low
concentr
nucleas
present
would
meaning
maintain
integr
function
dna
vaccin
furtherli
transfect
assay
perform
confirm
optim
np
ratio
lipiddna
ratio
might
contribut
high
express
dna
vaccin
target
cell
hek
cell
use
model
evalu
transfect
effici
express
luciferas
report
enzym
gfp
green
fluoresc
protein
shown
fig
transfect
effici
csluc
differ
np
ratio
determin
luciferas
assay
ph
result
indic
optim
np
ratio
agre
previou
result
transfect
effici
alcsluc
optim
variou
lipiddna
ratio
ww
peiluc
np
use
posit
control
fig
result
show
transfect
effici
alcsluc
notabl
enhanc
lipiddna
ratio
ww
increas
transfect
imag
csgfp
alcsgfp
differ
np
ratio
lipiddna
ratio
shown
fig
obviou
better
transfect
result
verifi
alcsdna
csdna
final
optim
alcsdna
prepar
np
ratio
lipiddna
ratio
ww
ratio
physicochem
properti
np
influenc
stabil
mucos
adsorpt
transport
three
indispens
step
success
mucos
immun
intranas
administr
np
might
challeng
ph
environ
chang
vivo
thu
influenc
ph
chang
csdna
alcsdna
examin
shown
fig
al
csdna
found
signific
chang
size
zeta
potenti
especi
ph
increas
size
sharpli
increas
micron
scale
zeta
potenti
decreas
mv
indic
disintegr
ternari
complex
structur
howev
size
zeta
potenti
cs
dna
chang
significantli
studi
surfac
morpholog
prepar
np
tem
indic
csdna
irregular
shape
fig
alcsdna
almost
spheric
ph
al
act
core
fig
ph
increas
disintegr
alcsdna
observ
fig
expect
phmediat
dna
releas
alcsdna
verifi
fig
result
indic
addit
al
csdna
homogen
alcsdna
np
form
addit
al
might
facilit
dna
releas
alcsdna
phmediat
manner
assum
increas
nasal
resid
time
antigen
one
key
featur
enhanc
nasal
immun
respons
nasal
resid
time
al
monitor
ivi
spectrum
imag
system
fig
found
fluoresc
two
np
caviti
exceed
total
fluoresc
administr
within
h
fig
howev
comparison
csdna
power
abil
prolong
nasal
resid
time
verifi
alcsdna
csdna
alcsdna
also
evalu
mucin
adsorpt
abil
measur
mucoadhes
abil
deliveri
system
fig
csdna
found
retain
mucin
mgmg
dna
nake
dna
mgmg
dna
alcsdna
power
adhes
abil
csdna
sinc
mucin
adsorpt
reach
mgmg
dna
howev
increas
fold
less
result
indic
addit
al
csdna
complex
increas
nasal
resid
time
dna
vaccin
mucos
surfac
prolong
resid
time
nasal
caviti
offer
sustain
antigenmucosa
interact
without
clear
away
order
investig
transport
np
nasal
mucosa
fitccsdna
alfitccsdna
administr
rat
nasal
mucosa
h
transport
np
monitor
clm
prove
fitc
modif
cs
interfer
dna
entrap
capac
releas
tabl
fig
shown
fig
alfitcc
dna
found
penetr
deep
mucosa
layer
mm
within
h
fluoresc
intens
increas
peak
valu
depth
mm
last
depth
mm
decreas
gradual
deeper
depth
imag
section
x
z
z
taken
depth
mm
insid
mucosa
also
shown
clearli
show
alfitccsdna
intern
mucos
epithelia
transport
deeper
region
mucos
area
howev
shown
fig
less
fitccsdna
found
penetr
mucosa
layer
three
dimension
reconstruct
anim
clm
result
shown
movi
movi
result
provid
evid
alcsdna
power
penetr
mucosa
layer
better
understand
mechan
lead
power
transport
alcsdna
nasal
mucosa
cell
use
model
investig
mucosa
permeabl
intracellular
uptak
teer
decreas
cell
monolay
measur
mucos
epitheli
permeabl
interestingli
although
csdna
alcsdna
show
power
decreas
teer
obviou
differ
two
np
fig
percentag
cell
intern
fitclabel
np
fluoresc
intens
quantifi
flow
cytometri
shown
fig
percentag
fluoresc
cell
fluoresc
intens
enhanc
notabl
incorpor
al
result
indic
incorpor
al
csdna
might
increas
intracellular
uptak
epitheli
cell
without
affect
inher
mucos
permeabl
order
evalu
potenti
pgjapvax
load
csbase
np
induc
specif
mucos
system
humor
respons
femal
balbc
mice
divid
five
group
n
vaccin
indic
formul
via
im
rout
assess
specif
antipac
antibodi
level
salivari
serum
sampl
fig
signific
last
salivari
antipac
siga
antibodi
respons
elicit
administr
alcsdna
mucos
immun
induc
alcsdna
group
earli
week
first
vaccin
significantli
higher
level
nake
dna
group
csdna
group
immun
effect
strengthen
week
slightli
decreas
week
contrast
signific
differ
siga
product
csdna
group
nake
dna
group
time
interv
addit
longterm
mucos
immun
found
last
least
week
alcsdna
group
week
siga
respons
observ
nake
dna
group
nake
dna
im
group
indic
dna
without
deliveri
system
seem
trigger
effect
siga
respons
via
im
rout
mice
vaccin
mg
pgjapvax
via
im
administr
strong
serum
respons
last
least
week
fig
accord
major
previou
studi
show
success
dna
immun
obviou
specif
igg
respons
observ
pb
group
nake
dna
group
csdna
group
addit
specif
igg
respons
alcsdna
group
present
statist
signific
week
compar
csdna
group
result
indic
alcsdna
attract
mucos
dna
vaccin
deliveri
system
induc
strong
mucos
respons
howev
type
intens
immun
respons
greatli
affect
administr
rout
vaccin
deliveri
system
potenti
cytotox
taken
seriou
consider
cytotox
pei
dna
csdna
alcsdna
perform
mtt
assay
follow
h
incub
raw
cell
fig
cs
dna
alcsdna
show
similar
high
cell
viabil
vari
concentr
cell
viabil
observ
csdna
alcsdna
group
concentr
mgml
peidna
show
high
cytotox
even
low
concentr
mgml
concentr
reach
mgml
cell
viabil
pei
dna
less
result
indic
alc
dna
minim
cytotox
toward
phagocyt
cell
believ
develop
vaccin
mutan
might
effect
strategi
prevent
control
occurr
dental
cari
though
deliveri
pgjap
vaxbupivacain
induc
mucos
humor
system
respons
variou
anim
mice
rat
monkey
bupivacain
safe
use
immun
adjuv
meanwhil
singl
pgjapvax
seem
work
ineffici
via
administr
present
studi
demonstr
incorpor
al
cspgjapvax
enhanc
cell
uptak
cell
transfect
mucoadhes
properti
observ
final
alcsdna
found
induc
strong
mucos
rel
weak
system
antibodi
respons
follow
immun
balbc
mice
pka
valu
cs
dopg
respect
formul
prepar
water
ph
ioniz
cs
dna
dopg
form
ternari
complex
al
csdna
electrostat
interact
posit
charg
amino
group
cs
neg
charg
phosphat
group
dna
dopg
tem
result
reveal
alcsdna
rel
spheric
shape
al
core
ph
fig
theoret
cs
dna
al
mix
togeth
two
domain
csdna
csal
form
electrostat
interact
thu
like
dna
al
cs
separ
yield
two
type
domain
csdna
csal
bridg
cs
chain
alcsdna
np
fig
similar
twodomain
structur
report
incorpor
poli
gglutam
acid
cs
dna
complex
alcsdna
micron
scale
size
neg
zeta
potenti
ph
increas
fig
process
cs
amin
group
deproton
cs
becam
hydrophob
electrostat
interact
longer
signific
hydrogen
bond
might
drive
forc
csdna
bind
csal
bind
csdna
csal
carri
neg
charg
electrostat
repuls
two
result
disintegr
alcsdna
structur
favor
releas
load
dna
might
explain
dna
releas
alc
dna
phdepend
fig
contrast
alcsdna
report
bind
cs
dna
even
tighter
csdna
complex
ph
increas
physiolog
environ
csdna
complex
disrupt
notic
ph
environ
cytoplasm
nuclei
cell
ph
infer
intern
cell
alcsdna
could
rapidli
releas
signific
amount
load
dna
facilit
express
encod
protein
report
nuclear
transloc
gene
express
achiev
unless
dna
releas
complex
insid
cell
anoth
reason
might
respons
high
tranfect
effici
alc
dna
dope
one
compon
al
report
promot
membran
destabil
suggest
facilit
gene
transfect
pg
lipid
prove
nucleusfusogen
abil
might
facilit
nuclear
transloc
dna
addit
nasal
mucos
ph
approxim
favor
stabil
alc
dna
without
dna
releas
intern
excitingli
enhanc
gene
express
nasal
mucosa
observ
fig
impli
alcsdna
might
power
csdna
use
nasal
mucosa
vaccin
comparis
fluoresc
signal
detect
nake
dna
use
interestingli
alcsdna
show
longer
nasal
resid
time
compar
csdna
fig
verifi
prolong
antigen
retent
nasal
caviti
especi
import
enhanc
mucos
immun
alcsdna
csdna
power
bioadhes
abil
compar
nake
dna
differ
two
np
obviou
enough
fold
fig
posit
charg
cs
chain
could
provid
strong
bioadhes
neg
charg
mucos
surfac
like
cation
complex
similarli
signific
differ
open
cell
tight
conjunct
observ
two
np
fig
explain
cs
deriv
consid
abl
transient
open
tight
junction
cell
surprisingli
enhanc
intracellular
uptak
verifi
alcsdna
csdna
fig
physicochem
properti
particl
size
surfac
charg
shape
molecular
weight
composit
play
key
role
cellular
uptak
np
dope
lipid
pack
paramet
valu
known
adopt
invert
hexagon
structur
favor
membran
destabil
enhanc
intracellular
uptak
hand
report
globular
gc
glyco
chitosan
np
show
enhanc
distribut
cell
compar
irregular
gc
polym
power
mucos
permeabl
enhanc
intracellular
uptak
result
explain
alcsdna
deliv
mucos
cell
fig
result
prolong
nasal
resid
time
csdna
gradual
remov
mucociliari
clearanc
anoth
reason
might
taken
consider
infer
spheric
alcsdna
penetr
mucu
gel
pore
mucin
fiber
contact
mucos
epithelia
howev
network
shape
csdna
might
trap
lumin
mucu
layer
steric
hindranc
final
gradual
remov
mucociliari
clearanc
detail
exact
mechan
need
explor
verifi
prolong
antigen
retent
nasal
caviti
especi
import
enhanc
mucos
immun
expect
alcsdna
power
induc
specif
mucos
system
respons
compar
tradit
use
csdna
system
advantag
increas
saliva
antipac
siga
product
obviou
aggreg
unattach
mutan
interfer
mutan
pathogenesi
colon
tooth
surfac
nake
dna
without
deliveri
system
via
challeng
ciliari
clearanc
nucleas
degrad
difficulti
uptak
express
make
uneffici
induc
mucos
system
immun
respons
indic
sever
report
contrast
solubl
antigen
particul
could
preferenti
taken
cell
follow
nasal
administr
notic
rel
less
popul
cell
nalt
notori
difficulti
transfect
apc
nonvir
vector
consid
non
cell
apc
target
strategi
might
also
effect
nasal
mucos
immun
fact
report
new
pathway
polymerbas
dna
vaccin
deliveri
via
bystand
cell
without
direct
target
apc
success
addit
antipac
siga
product
vagin
wash
evalu
fig
result
confirm
al
csdna
induc
distal
mucos
immun
respons
agre
studi
stimul
lymphocyt
nalt
distribut
mucos
site
vagina
result
also
confirm
advantag
incorpor
al
final
alcsdna
show
minim
cytotox
favor
quick
clearanc
via
digest
tract
fig
obviou
distribut
alcsdna
detect
organ
heart
spleen
liver
kidney
except
lung
remind
us
pay
close
attent
drug
adsorpt
lung
via
administr
studi
success
develop
alcsdna
nanoparticl
system
potent
carrier
nasal
mucos
immun
alcsdna
exhibit
capabl
mucoadhes
phmediat
dna
releas
induc
effect
mucos
immun
respons
deliveri
system
al
exhibit
advantag
improv
intranas
deliveri
tradit
use
csdna
system
chitosan
exhibit
mucoadhes
properti
condit
phdepend
dna
releas
behavior
furthermor
alcsdna
show
minim
cytotox
favor
clearanc
via
digest
tract
alcsdna
np
safe
effect
system
might
potenti
use
adjuvantfre
dna
vaccin
deliveri
system
mucos
immun
